Cargando…

Congenital Hemolytic Anemias: Is There a Role for the Immune System?

Congenital hemolytic anemias (CHAs) are a heterogeneous group of rare hereditary conditions including defects of erythrocyte membrane proteins, red cell enzymes, and disorders due to defective erythropoiesis. They are characterized by variable degree of anemia, chronic extravascular hemolysis, reduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaninoni, Anna, Fermo, Elisa, Vercellati, Cristina, Marcello, Anna Paola, Barcellini, Wilma, Bianchi, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324678/
https://www.ncbi.nlm.nih.gov/pubmed/32655575
http://dx.doi.org/10.3389/fimmu.2020.01309
_version_ 1783551989019312128
author Zaninoni, Anna
Fermo, Elisa
Vercellati, Cristina
Marcello, Anna Paola
Barcellini, Wilma
Bianchi, Paola
author_facet Zaninoni, Anna
Fermo, Elisa
Vercellati, Cristina
Marcello, Anna Paola
Barcellini, Wilma
Bianchi, Paola
author_sort Zaninoni, Anna
collection PubMed
description Congenital hemolytic anemias (CHAs) are a heterogeneous group of rare hereditary conditions including defects of erythrocyte membrane proteins, red cell enzymes, and disorders due to defective erythropoiesis. They are characterized by variable degree of anemia, chronic extravascular hemolysis, reduced erythrocyte life span, splenomegaly, jaundice, biliary lithiasis, and iron overload. Although few data are reported on the role of the immune system in CHAs, several immune-mediated mechanisms may be involved in the pathogenesis of these rare diseases. We reported in ~60% of patients with hereditary spherocytosis (HS), the presence of naturally-occurring autoantibodies (NAbs) directed against different membrane proteins (α- and β-spectrin, band 3, and dematin). Positive HS subjects showed a more hemolytic pattern and NAbs were more evident in aged erythrocytes. The latter is in line with the function of NAbs in the opsonization of damaged/senescent erythrocytes and their consequent removal in the spleen. Splenectomy, usually performed to reduce erythrocyte catheresis and improve Hb levels, has different efficacy in various CHAs. Median Hb increase is 3 g/dL in HS, 1.6–1.8 g/dL in pyruvate kinase deficiency (PKD), and 1 g/dL in congenital dyserythropoietic anemias (CDA) type II. Consistently with clinical severity, splenectomy is performed in 20% of HS, 45% of CDAII, and in 60% of PKD patients. Importantly, sepsis and thrombotic events have been registered, particularly in PKD with a frequency of ~7% for both. Furthermore, we analyzed the role of pro-inflammatory cytokines and found that interleukin 10 and interferon γ, and to a lesser extent interleukin 6, were increased in all CHAs compared with controls. Moreover, CDAII and enzymatic defects showed increased tumor necrosis factor-α and reduced interleukin 17. Finally, we reported that iron overload occurred in 31% of patients with membrane defects, in ~60% of CDAII cases, and in up to 82% of PKD patients (defined by MRI liver iron concentration >4 mg Fe/gdw). Hepcidin was slightly increased in CHAs compared with controls and positively correlated with ferritin and with the inflammatory cytokines interleukin 6 and interferon γ. Overall the results suggest the existence of a vicious circle between chronic hemolysis, inflammatory response, bone marrow dyserythropoiesis, and iron overload.
format Online
Article
Text
id pubmed-7324678
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73246782020-07-10 Congenital Hemolytic Anemias: Is There a Role for the Immune System? Zaninoni, Anna Fermo, Elisa Vercellati, Cristina Marcello, Anna Paola Barcellini, Wilma Bianchi, Paola Front Immunol Immunology Congenital hemolytic anemias (CHAs) are a heterogeneous group of rare hereditary conditions including defects of erythrocyte membrane proteins, red cell enzymes, and disorders due to defective erythropoiesis. They are characterized by variable degree of anemia, chronic extravascular hemolysis, reduced erythrocyte life span, splenomegaly, jaundice, biliary lithiasis, and iron overload. Although few data are reported on the role of the immune system in CHAs, several immune-mediated mechanisms may be involved in the pathogenesis of these rare diseases. We reported in ~60% of patients with hereditary spherocytosis (HS), the presence of naturally-occurring autoantibodies (NAbs) directed against different membrane proteins (α- and β-spectrin, band 3, and dematin). Positive HS subjects showed a more hemolytic pattern and NAbs were more evident in aged erythrocytes. The latter is in line with the function of NAbs in the opsonization of damaged/senescent erythrocytes and their consequent removal in the spleen. Splenectomy, usually performed to reduce erythrocyte catheresis and improve Hb levels, has different efficacy in various CHAs. Median Hb increase is 3 g/dL in HS, 1.6–1.8 g/dL in pyruvate kinase deficiency (PKD), and 1 g/dL in congenital dyserythropoietic anemias (CDA) type II. Consistently with clinical severity, splenectomy is performed in 20% of HS, 45% of CDAII, and in 60% of PKD patients. Importantly, sepsis and thrombotic events have been registered, particularly in PKD with a frequency of ~7% for both. Furthermore, we analyzed the role of pro-inflammatory cytokines and found that interleukin 10 and interferon γ, and to a lesser extent interleukin 6, were increased in all CHAs compared with controls. Moreover, CDAII and enzymatic defects showed increased tumor necrosis factor-α and reduced interleukin 17. Finally, we reported that iron overload occurred in 31% of patients with membrane defects, in ~60% of CDAII cases, and in up to 82% of PKD patients (defined by MRI liver iron concentration >4 mg Fe/gdw). Hepcidin was slightly increased in CHAs compared with controls and positively correlated with ferritin and with the inflammatory cytokines interleukin 6 and interferon γ. Overall the results suggest the existence of a vicious circle between chronic hemolysis, inflammatory response, bone marrow dyserythropoiesis, and iron overload. Frontiers Media S.A. 2020-06-23 /pmc/articles/PMC7324678/ /pubmed/32655575 http://dx.doi.org/10.3389/fimmu.2020.01309 Text en Copyright © 2020 Zaninoni, Fermo, Vercellati, Marcello, Barcellini and Bianchi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Zaninoni, Anna
Fermo, Elisa
Vercellati, Cristina
Marcello, Anna Paola
Barcellini, Wilma
Bianchi, Paola
Congenital Hemolytic Anemias: Is There a Role for the Immune System?
title Congenital Hemolytic Anemias: Is There a Role for the Immune System?
title_full Congenital Hemolytic Anemias: Is There a Role for the Immune System?
title_fullStr Congenital Hemolytic Anemias: Is There a Role for the Immune System?
title_full_unstemmed Congenital Hemolytic Anemias: Is There a Role for the Immune System?
title_short Congenital Hemolytic Anemias: Is There a Role for the Immune System?
title_sort congenital hemolytic anemias: is there a role for the immune system?
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324678/
https://www.ncbi.nlm.nih.gov/pubmed/32655575
http://dx.doi.org/10.3389/fimmu.2020.01309
work_keys_str_mv AT zaninonianna congenitalhemolyticanemiasistherearolefortheimmunesystem
AT fermoelisa congenitalhemolyticanemiasistherearolefortheimmunesystem
AT vercellaticristina congenitalhemolyticanemiasistherearolefortheimmunesystem
AT marcelloannapaola congenitalhemolyticanemiasistherearolefortheimmunesystem
AT barcelliniwilma congenitalhemolyticanemiasistherearolefortheimmunesystem
AT bianchipaola congenitalhemolyticanemiasistherearolefortheimmunesystem